Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

NCT00021463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

342

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Lipodystrophy

Interventions

DRUG: Abacavir sulfate, Lamivudine and Zidovudine
DRUG: Abacavir sulfate
DRUG: Efavirenz
DRUG: Nevirapine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)